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Examination of 18 cobras brought to three hospitals in the Mandalay Region by patients 
bitten or spat at by them distinguished 3 monocled cobras (Naja kaouthia) and 15 
Mandalay spitting cobras (N. mandalayensis), based on their morphological 
characteristics. We confirm and extend the known distributions and habitats of both N. 
mandalayensis and N. kaouthia in Upper Myanmar. Clinical symptoms of local and 
systemic envenoming by N. mandalayensis are described for the first time. These 
included local swelling, blistering and necrosis and systemic neurotoxicity. More 
information is needed about the clinical phenotype and management of bites by N. 
mandalayensis, the commoner of the two cobras in Upper Myanmar. Since the current 
cobra antivenom manufactured in Myanmar has lower pre-clinical efficacy against N. 
mandalayensis than N. kaouthia, there is a need for more specific antivenom therapy.   
 
Highlights: 
• The Mandalay spitting cobra (Naja mandalayensis) is much more common that 
the monocle cobra (N. kaouthia) in Upper Myanmar 
• Injuries caused by spitting of venom and bites were admitted to three hospitals 
in Mandalay Division 
• The known distribution of both species of cobra is extended 
• Naja mandalayensis envenoming causes neurotoxicity as well as local tissue 
damage 
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• The only available cobra antivenom in Myanmar may not be adequate for 
treating envenoming by N. mandalayensis  
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Snakebite is a serious medical problem in rural areas of Myanmar. In 2014, 15,080 
snakebites and 305 snakebite deaths were recorded by the Myanmar Ministry of Health 
(Regional Office for South-East Asia, World Health Organization, 2016), but a recent 
community-based study has suggested a much higher figure of perhaps 2,000 deaths 
per year (Mahmood et al., 2018). In Myanmar, there are three families of medically 
important venomous snakes: Elapidae (kraits, cobras, king cobra, Asian coral snakes 
and sea-snakes), Viperidae (Fea’s viper, Russell’s viper and pit-vipers), and Natricidae 
(red-necked keel-back, Rhabdophis subminiatus helleri and possibly some of the other 
six Myanmar species in this genus, including those formerly assigned to 
Macropisthodon) (Leviton et al., 2008). Species that are likely to cause snakebite 
envenoming include Bungarus magnimaculatus, B. wanghaotingi, Naja kaouthia, N. 
mandalayenis, Daboia siamensis, Trimeresurus (Trimeresurus) albolabris, T. (T.) 
erythrurus, and T. (T.) purpureomaculatus. Of these, Eastern Russell’s vipers (D. 
siamensis) are by far the most important, causing more than 50% of medically 
significant snakebite cases and fatalities. In 2016, 16,767 snakebite cases were reported 
in Myanmar, with 2,566 cases in the Mandalay Region alone (Ministry of Health and 
Sports, Health Statistics Data, 2016).  
Cobras are among the most familiar venomous snakes in Myanmar and are 
responsible for a considerable number of severe snakebite envenomings. They are 
distributed throughout the country, although records are so far lacking for the East 
(Shan, Kayah and Kayin states) and South-East (Mon State and Tanintharyi Division) 
(Leviton et al., 2008).  
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It was long thought that Myanmar harboured only one species of cobra, N. kaouthia, 
easily recognisable by the single eye pattern on the back of its hood. However, back 
in 1900, Captain MD Goring Jones of the 2nd Durham Light Infantry, wrote to the 
Journal of the Bombay Natural History Society describing the plight of a colleague 
who attacked a snake seen near his quarters. “The snake made a dart at him but 
fortunately missed its aim. Some of the poison or saliva was ejected into (his) eye, 
causing instant and great pain, and the eyelids and parts round swelled up quickly to 
the size of a large hen’s egg. The snake was killed and found to be a small black cobra 
about 3 feet 4 inches in length. (The victim) went to hospital and after a painful night 
recovered his eyesight” (Goring Jones; 1900). This was the first clue that there might 
be spitting cobras in Upper Myanmar. These suspicions were supported by experience 
of keepers at Mandalay and Yangon zoos who were spat at by cobras (Dr U Tun-Pe, 
personal communication) and by the discovery of 6 specimens in the Stockholm 
Museum “with highly modified spitting fangs from Rangoon or Mandalay” which, on 
the basis of multivariate analysis of a range of morphological characters, “were not 
clearly assignable to any of the nine species (of Asian Naja) currently recognized” 
(Wüster and Thorpe, 1992). These authors predicted that “a species of cobra with 
spitting fangs occurs sympatrically with N. kaouthia in parts of Burma”. In India, 
some populations of N. kaouthia are capable of spitting their venom. In 2010, one of 
us (JW) observed this behavior in an adult N. kaouthia, captured near Kolkata in West 
Bengal (NEW Fig. 1). Vishal Santra, who had rescued the snake, had seen spitting by 
others of this species on multiple occasions (Santra and Wüster, 2017). However, spiting 
by this species has never been reported in Myanmar. 
Eventually, Slowinski and Wüster described the Mandalay spitting cobra (N. 
mandalayensis) as a new species from central Myanmar, based on morphological and 
molecular analyses (Slowinski and Wüster, 2000). It is apparently restricted to the 
central arid regions of Myanmar, thriving around villages and in agricultural land 
(Leviton et al. 2008). The present study aims to investigate and compare the 
morphometric characters of N. kaouthia and N. mandalayenis in the Mandalay Region, 
including an examination of their sympatry, and to describe, for the first time, clinical 




Snakes brought in by patients who had been bitten or spat at were collected from 
December 2016 to October 2018 at three hospitals (Mandalay General (MGH), 
Kyaukse District and Madaya Township Hospitals) in Mandalay Division, Myanmar as 
part of the Myanmar Snakebite Project (White et al; 2019a,b). The body cavities of all 
specimens were incised along the ventral surface and the snakes preserved in 70% 
ethanol for further studies and deposited at the Department of Zoology, Institute of 
Medicine, Mandalay. A number of morphological characters, lepidosis, colour pattern 
and body proportions were recorded (Table 1). The number of ventral scales from the 
head to vent was counted according to Dowling (1951). Thorpe (1975) pointed out that 
using ventral scales and subcaudal scales as units to define the position of 
morphological features was unsatisfactory because the numbers of scales varied 
between specimens. To correct for this variation, percent ventral scale (%VS) position 
was used to indicate the position at which dorsal rows of scales were counted 
(Slowinski and Wüster, 2000).   
Clinical data were recorded manually on proformas by medical officers employed by 
the Australian Department of Foreign Affairs and Trade (DFAT)-funded Myanmar 
Snakebite Project (MSP), then entered into a tailor-made FileMakerPro database 
(White et al, 2019b). We also reviewed the original hospital case records to confirm the 
data and collect additional information. Dead snakes brought by patients were 
collected, identified, measured and labelled with individual tags bearing an ID number 





Snakes: eighteen out of a total of 212 dead snakes collected were cobras (Table 1). 
Thirteen patients proved to have been bitten by N. mandalayensis and 3 by N. kaouthia. 
Two patients were spat at by N. mandalayensis. All 15 specimens of N. mandalayensis 
had been encountered in Myanmar’s central dry region -  in Shwebo Township (1),  
Sagaing Region; Kume (1), Kyaukse (4), Myitthar (2), Natogyi (2) Sintgaing (1), 
Thabeikgyin (1), Wun Dwin (1), and Pyin Oo Lwin (Shan Highland) (1) townships, 
Mandalay Region; and Salin Township (1) in Magway Region (Fig. 2). The three 
specimens of N. kaouthia had been killed, one each in Kyaukse (1) and Sintgaing (1), 
Mandalay Region and Kaw Lin (1), Sagaing Region. The two species were evidently 
sympatric in Kyaukse and Sintgaing.  
The following morphological differences were used to distinguish the two cobra 
species:  
(1) Fangs: all the fangs of N. mandalayensis were examined but some were broken. 
Wherever possible, we examined and measured the position and size of fang orifices, 
an important adaptation for spitting. The length of fangs was measured as the straight-
line distance between the distal end of the basal orifice and the tip of the fang according 
to Wüster and Thorpe (1992). These measurements were taken by digital caliper with 
an accuracy of 0.01mm. The fang length of N. mandalayensis was 5.3 mm (SD 0.29, 
n=4) and the discharge orifice was 0.26 mm (SD 0.02, n=3) in length (Fig. 3 A-C). The 
fang has no groove and its discharge orifice is located away from the tip of the fang 
whereas in N. kaouthia and N. naja the orifice is longer, in a groove, and closer to the 
tip (Fig. 3 D-E). 
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(2) Hood markings: none of the 15 specimens of N. mandalayensis showed any clear 
dorsal hood marking, although a faint suggestion of a spectacle marking was discernible 
in a few. All specimens of N. kaouthia had a monocle marking (Fig. 4A and B).  
(3) Throat pattern: all specimens of N. mandalayensis showed dark mottling under 
the throat from the first ventral scale to the first throat band (between ventral scales 1-
13), while all N. kaouthia had a pale, creamy-coloured throat with two distinctive lateral 
black spots (“false eyes”) within a circular pale area. N. mandalayensis usually has 
pale-coloured ventrals/subcaudals distal to the throat area, whereas in N. kaouthia these 
are usually dark grey. Ventral and dorsal scale counts overlapped between the two 
species, but their dorsal hood markings and ventral throat markings were quite different 
(Fig. 4 A and B, Fig. 5). 
A living specimen of N. mandalayensis from Taungdwingyi was photographed and is 
included to show some of the distinguishing features of this species (Figs. 6 A and B). 
Patients: the total number of cobra bite and spit victims recorded was 18 (15 males and 
3 females). Some victims were farmers, bitten while working (44%). One victim was 
bitten (5%) when he stepped on the snake accidently while riding a motorbike, four 
were bitten in their homes (22%), while the remainder were bitten under unknown 
circumstances (29%).  
Clinical features (Table 2)  
Symptoms and signs: most patients were bitten on their feet. Eight of the N. 
mandalayensis victims developed local swelling, with local bleeding from the bite 
wounds in 2, blistering in 2, local lymphadenopathy in 2, and local necrosis in 4. Local 
infection was suspected in 3. All 3 N. kaouthia victims developed local swelling, with 
local bleeding or local lymphadenopathy in 2 of them. One or more of the following 
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systemic neurotoxic symptoms/signs were recorded in 5 of the 15 patients bitten by N. 
mandalayensis (33%): bilateral ptosis, blurred vision (a subjective symptom possibly 
attributable to paralysis of visual accommodation or external ophthalmoplegia), slurred 
speech, inability fully to open the mouth, difficulty in swallowing, respiratory distress, 
and drowsiness. Two of the 3 patients bitten  by N. kaouthia (67%) had either blurred 
vision or sleepiness.  
Two patients had venom spat into their eyes by N. mandalayensis, but they were not 
bitten. There was redness, lacrimation, periocular swelling and a burning sensation in 
the affected eyes (Table 2).   
Laboratory tests: results were available in 7 N. mandalayensis and 1 of the N. kaouthia 
cases. They were normal apart from raised white blood cell counts in 2 of the N. 
mandalayensis cases and a mildly raised serum creatinine in one N. kaouthia case. 
There was no suggestion of coagulopathy in any of these cobra-bite cases: the  20 
minute whole blood clotting test (20WBCT) was negative (clotting) in the 13 cases 
where a result was recorded; no patient had clinical evidence of systemic bleeding. 
Treatment: no patient required intubation or assisted ventilation. Antivenom was 
administrated to 60% (9 out of 15) of victims of N. mandalayensis and in two out of 
three bitten by N. kaouthia. Most received Burma Pharmaceutical Industry (BPI) cobra 
antivenom; only 2 patients received Indian polyvalent antivenom (producer unknown). 
The dose was four to fifteen vials (40-150 mL). Only one (acute, pyrogenic) antivenom 
reaction was recorded. The patients who received antivenom were discharged after 
periods of observation ranging from 2 to 7 days.  
Illustrative case report (Table 2, Case 10) 
	
A 40 year old farmer was bitten on his right foot by a cobra at 1900h in October 2018 
in Yin Ma Village, Salin, Minbu District, Magway Division. The snake was killed and 
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brought in by the patient and was later identified as a Naja mandalayensis 116cm in 
total length. By 2200h, he had developed slurred speech and difficulty swallowing, 
prompting his travelling 50 km over night to Seikphyu Township Hospital, arriving 
the following morning at 0600h. There, he received 4 vials of BPI (Burma 
Pharmaceutical Industry) Naja kaouthia antivenom after which his symptoms were 
said to have improved. However, because of his need for intensive care, he then 
transferred across the Ayeyarwady River, 270 km to Mandalay General Hospital, 
arriving at 1300h, 18 hours post-bite. On admission, he appeared drowsy (probably 
due to bilateral ptosis - see below) and complained of blurred vision, had difficulty 
swallowing and could not open his mouth. One-and-a-half hours later he was fully 
rousable (GCS 15/15) and febrile. His breathing was shallow, rate 20/min, but oxygen 
saturation was 98% while breathing 2 L/min of oxygen via nasal catheters. His cough 
was ineffective. He had mild ptosis, limited mouth opening (maximum inter-dental 
distance 2cm), mild dysarthria and dysphagia. Power in all four limbs was normal 
(5/5). He could raise his head normally and sit up unassisted.  Examination of the bite 
site showed local swelling (2+) with skin necrosis (1+). The right inguinal lymph 
nodes were enlarged and tender (1+). Laboratory investigations were normal (blood 
urea of 7.8 mmol/L, serum creatinine 86 μmol/L, plasma sodium 140 mmol/L, 
potassium 3.9 mmol/L, chloride 102 mmol/L, bicarbonate 25 mmol/L, haemoglobin 
13.4 gm/L) apart from a raised white blood cell count of 15,150/ml consistent with 
the inflammatory response to systemic envenoming. Because of persistent neurotoxic 
symptoms, he was given a further 4 vials of BPI Naja kaouthia antivenom, in the 
emergency department, 20 hours post-bite. Fourteen hours later, he was said to be 
stable. Subsequently, his symptoms improved and he was moved out of ICU to a 
general medical ward. Three days post-bite, the right leg remained swollen. The bite 
site felt warm, had developed blistering, and was diffusely tender. A course of 
intravenous levofloxacin and metronidazole was started and tetanus toxoid was 







The venom apparatus and fangs of the Mandalay spitting cobra (N. mandalayensis) are 
adapted for spitting its venom defensively towards the eyes of perceived enemies. 
Compared to non-spitting cobras, the orifice of the venom duct in spitting species is 
smaller and situated further from the tip of the fang (Wüster et al., 1992; Slowinski and 
Wüster, 2000; Chu et al., 2010). Like Goring Jones (1900) more than a century earlier, 
Tun-Pe et al., (2002) reported ophthalmia caused by spitting of venom. Two villagers 
in the Mandalay Region and 6 snake keepers in the Mandalay Zoo (the Yadanabon 
Zoological Gardens) and Burma Pharmaceutical Industry’s snake farm were spat at. 
Symptoms included pain and redness of the eyes, swelling and itching that usually 
resolved overnight. However, one 17-year-old girl suffered impairment of vision and 
unreactive pupils that resolved completely only after 3 days. 
The medical importance and clinical features of N. mandalayensis envenoming in 
Myanmar, relative to those of the monocled cobra N. kaouthia were largely unknown. 
White et al., (2019a) assumed that the clinical effects of envenoming by N. 
mandalayensis involved local tissue injury with little or no neurotoxicity. However, we 
describe here, for the first time, clinical features of proven N. mandalayensis 
envenoming: local pain, swelling, numbness, lymphadenopathy, blistering and necrosis 
and systemic neurotoxic symptoms/signs including ptosis, blurred vision, slurred 
speech, inability to open the mouth, difficulty in swallowing and respiratory distress. 
This objective evidence of systemic neurotoxic envenoming in 4 cases, in addition to 
severe local envenoming in 6 of the 15 cases, is consistent with anecdotal accounts from 
physicians working in Mandalay, Sagaing and Magway Regions, and with reports of 
envenoming by two other SE Asian species of spitting cobra, N. siamensis (Wüster et 
al., 1997) and N. sumatrana (Reid, 1964). The clinical phenotype needs to be confirmed 
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by larger prospective studies in which there is rigorous clinical documentation of 
neurological signs and identification of the biting snake.  
Unfortunately, clinical signs do not differentiate between N. mandalayensis and N. 
kaouthia envenoming, making it impossible to make a species diagnosis unless the dead 
snake is brought or photographed. Even if this evidence were available, medical staff 
in Myanmar are insufficiently aware of the two species of cobras to be able to identify 
them reliably. We recommend that the curriculum for training medical staff and 
national treatment guidelines should illustrate the distinctive morphological features 
(dorsal hood and ventral throat markings) that differentiate Myanmar’s two species of 
cobra. This may be clinically important because of what is known about the potency 
and neutralization of N. mandalayensis venom by the only cobra antivenom available 
in Myanmar, BPI (formerly MPF) cobra antivenom which is raised against N. kaouthia 
venom. Antivenom raised against the venom of one species of cobra may be ineffective 
in neutralizing the venom of other species because Asiatic Naja vary considerably in 
their venom composition (Wüster, 1996, Wüster and Thorpe, 1991). There is also 
variation in venom composition within a single species (Shashidharamurthy and 
Kemparaju, 2007). However, Aye-Aye-Myint et al., (2004) found that BPI cobra 
antivenom, neutralized the lethal effect of N. mandalayensis venom in mice, although 
this required a 10 times higher dose than was needed for N. kaouthia venom, despite 
the fact that the potency of N. mandalayensis venom, measured as the intravenous 
median lethal dose (LD50iv), was 56.1 µg/mouse, 10 times less potent than N. kaouthia 
venom (LD50iv 4.95 µg/mouse). Similarly, in Thailand, the LD50iv of Indo-Chinese 
spitting cobra venom (N. siamensis) (21.4 µg/mouse) was also less potent than N. 
kaouthia venom (LD50iv 6.61 µg/mouse) (Khow et al., 1997). These results in mice 
suggest that patients with systemic envenoming by N. mandalayensis may require 
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substantially larger doses of BPI cobra antivenom than the minimum initial dose of 4 
vials (40 mL) currently recommended for N. kaouthia envenoming in Myanmar. 
Therefore, higher doses of BPI cobra antivenom may be appropriate for victims of 
identified N. mandalayensis envenoming. Pre-clinical testing against N. mandalayensis 
venom of other regional Naja antivenoms, such as Thai Red Cross Society N. kaouthia 
and neuro-polyvalent, and Taiwan N. atra antivenoms, might prove informative. In 
future, BPI should be encouraged to investigate the relative effectiveness of their cobra 
antivenom to determine if N. mandalayensis and N. kaouthia venoms should be 
combined in production of a bivalent cobra antivenom.  
Prior to this study, Naja mandalayensis was known from only 20 specimens, some of 
them obtained from commercial snake collectors (Slowinski and Wüster, 2000). The 
activities of (now illegal) snake smugglers who trade cobras and Russell’s vipers for 
medicinal use in China may have led to a decline in their numbers in recent years. By 
dint of its restricted range and commercial exploitation, the IUCN Red List of 
Threatened Species (http://dx.doi.org/10.2305/IUCN.UK.2012-
1.RLTS.T192227A2058297.en) classifies it as “Vulnerable B1ab (iii,v) ver 3.1” 
(Wogan and Stuart, 2012). However, it is well known for its spitting habit among 
villagers in the central dry zone, and, in the early 2000s, within the space of one year, 
700 spitting cobras, ostensibly caught around Thazi in Mandalay Division, were 
brought by commercial snake catchers to the national antivenom producer, MPF 
(BPI). We can now confirm that, within the catchment areas of Mandalay, Kyaukse 
and Madaya hospitals, N. mandalayensis is the commoner species of cobra.  
 
Slowinski and Wüster (2000) believed its distribution to be restricted to the central dry 
zone of Myanmar - Mandalay, Magway and Sagaing Regions in dry forests and dry 
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acacia habitat where the precipitation is less than 1,000 mm of annual rainfall. We have 
confirmed this, with the 15 specimens brought to our three study sites, and 3 additional 
records from Kyaukse and Myingyan in Mandalay Region and Thaungdwingyi in 
Magway Region (Fig. 5). However, one of our specimens was collected from Zee Pin 
Gyi Village, Pyin Oo Lwin Township, which is located in the Shan Highlands at an 
elevation of approximately 700 m above sea level and has an annual rainfall exceeding 
1000 mm. However, snakes confiscated from illegal traders heading for the border are 
sometimes released into the wild, artificially introducing them into new environments. 
The distribution of N. kaouthia has been reported to exclude Mandalay Region. 
According to Leviton et al., 2008, “in the drier central region, spanning Mandalay, 
Magway [part], and Sagaing [part] Divisions, it (N. kaouthia) is replaced by Naja 
mandalayensis” (Leviton et al., 2008). However, our two specimens of N. kaouthia 
from Kyaukse and Sintgaing, Mandalay Region, together with a specimen collected in 
1913 in Pyawbwe, Mandalay Region (Museum of Bombay Natural History Society # 
BNHS 2263) establish its existence there, where it is sympatric with N. mandalayensis 
as in parts of Magway and Sagaing Regions.   
Conclusions 
 
Pending further studies, we conclude that, in the central dry zones of Mandalay, 
Sagaing and Magway Regions, the Mandalay spitting cobra is a species of medical 
importance, due both to its bites and defensive spitting behavior. Provisional evidence 
of cross-neutralising activity of BPI cobra antivenom raised against the venom of the 
more widespread monocled cobra is not entirely reassuring. Disparities between the 
lethal potency of the two cobra venoms and the median effective doses of antivenom 
suggest that the existing antivenom is unlikely to be effective against Mandalay spitting 
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cobra venom, unless given in higher doses. Precise identification of the cobra species 
involved in envenoming patients is required to provide more substantial clinical data, 
while further research on the effectiveness of existing BPI cobra antivenom in 
neutralizing spitting cobra venom will determine if a case for producing a bivalent BPI 
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Table 1. Relative parametric and meristic data recorded on Naja kaouthia and N. 
mandalayensis from the dry zone of Myanmar. 
 N. kaouthia (n= 3) N. mandalayensis (n= 15) 
Ventral scales 180-181 175-188 
Subcaudal scales 54-57 52-60 
Dorsal row at 10th ventral 25-26 26-27  
Dorsal rows at midbody 19-21 19-23 
Dorsal rows at 80% VS 
length 
15-16 14-18 
Dorsal hood marking monocle none 
Number of ventrals in 
first (anterior) dark throat 
band 
5-7 6-8 
Total length 33-92 cm  28-116 cm 
 
Table 2 (see new version attached) 
  





Species  Total length 








Laboratory Test Results 
(on admission) 
 
Number of vials 










116 cm R upper leg Bite marks, pain  Ptosis Urea 3 mmol/l 
Creatinine 75 μmol/l 
Sodium 143 mmol/l 
Potassium 3.8 mmol/l 
Chloride 104 mmol/l 
Bicarbonate 27 mmol/l 








53 cm  R hand Bite marks  
Swelling of 1/3 of  
limb, local  
numbness, local  
bleeding 
Blisters and  
local necrosis 
None Urea 4 mmol/L 4  
(acute pyrogenic 
reaction) 




60 cm  L lower leg Bite marks,   
Swelling of 1/3 of limb 
Bite site necrosis and 
infection 
 
Nausea and Vomiting 
Cyanosis  
Respiratory distress 
Creatinine 26 umol/L 
Urea 7 mmol/L 
Hb 11.8 gm/L 
Platelet 362,000 
4  




106 cm  R hand Bite mark, local pain  None Not done None 




43.5 cm  L foot Pain, local swelling,  




Bilateral ptosis, slurred 
speech, blurred vision, 
difficulty swallowing 
Urea 5.8 mmol/L 
 
8  




41.5 cm L Foot and  
R hand 
Bite marks, pain, local 
swelling  
Blurred vision Not done  4  




105 cm L foot Bite marks, local 
swelling  
None Urea 6.5 mmol/L 
Creatinine 65.6 μmol/L 
Sodium 147.5 mmol/L 
Potassium 2.9 mmol/L 
Chloride 106.7 mmol/L 
Bicarbonate 27.3 mmol/L 
Hb 13.7 gm/L 
Platelet 201,000 
4 




79 cm R hand Bite marks None Not done None 




28 cm L foot Bite marks, local pain  
 
Headache  Urea 3.6 mmol/L 
Creatinine 66 μmol/L 
Sodium 140 mmol/L 
Potassium 3.2 mmol/L 
Chloride 101 mmol/L 
Bicarbonate 25 mmol/L 
Hb 11.9 gm/L 
WBC 8,500 
 














116 cm  R foot Swelling of 2/3 of limb 
Pain at bite site 
Painful right inguinal 
lymph node enlargement 
Local blistering, 
possible infection and 
necrosis  
“Drowsiness”, ptosis, 
blurred vision,  
dysarthria, limited 
mouth opening etc. (see 
detailed Case History)  
Urea 7.8 mmol/L 
Creatinine 86 μmol/L 
Sodium 140 mmol/L 
Potassium 3.9 mmol/L 
Chloride 102 mmol/L 
Bicarbonate 25 mmol/L 
Hb 13.4 gm/L 
WBC 15,150 
4 + 4  













32 cm L hand Local swelling None Not done None 




43 cm L lower leg Local bite marks, local 
bleeding  
None Not done None 




92 cm L foot Bite marks, pain, 
swelling of left foot up 
to the calf 
Left tender inguinal 
Blurred vision Creatinine 143 μmol/L 
Urea 6.2 mmol/L 
Hb 15 gm/L 




lymphadenopathy  Platelet 280,000 
15 Age: 24 
Male 
Naja kaouthia 33 cm R hand Bite marks, local 
swelling, numbness  
Sleepiness Not done  4  
16 Age: 27 
Male 
Naja kaouthia 40 cm R foot Bite marks, local 
bleeding, swelling and 
pain  
None Not done None 
Spits  











Not done None 
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Captions to figures 
Figure 1 
Monocled cobra (Naja kaouthia) from near Kolkata, West Bengal, India spitting its 
venom at an earthenware vessel about 1 meter away. Inset shows tracks madeon the 
vessel by the two jets of venom (credit Julian White, 2010). To illustrate that some 
Indian populations of N. kaouthia are capable of spitting their venom defensively (see 
also Santra and Wüster, 2017). 
Figure 2 
Map of locations of cobra specimens. Key: red spot = Naja mandalayensis (this 
study); black triangle = N. kaouthia (this study); green square = N. mandalayensis 
(Slowinski	and	Wuster,	2000)	 
Figure 3 
Cobra fangs (credit Julian White) 
A-C Discharge orifices of three Naja mandalayensis showing lack of grooves  
D Naja kaouthia, from Myanmar showing discharge orifices set in a groove 
E Naja naja, from Kolkata showing discharge orifice set in a groove 
Figure 4  
	 21	
Monocled cobra, Naja kaouthia, specimens from Kyaukse: showing a - monocle 
pattern on dorsal surface of hood in a preserved specimen; and b - lack of dark spots 
on the throat above the anterior dark band and the two “false eye” spots laterally  
Figure 5 
Mandalay spitting cobra, Naja mandalayensis, specimen from Kyaukse: showing lack 
of dorsal monocle marking, dark spots on throat in front of anterior dark band (on 
ventral scales 17-23), and pale coloured ventral and sub-caudal scales. 
Figure 6  
Mandalay spitting cobras (N. mandalayensis): Living specimen from Taungdwingyi 
showing: a - barely-discernible spectacle/U-shaped hood mark visible in the 
interstitial skin of the dorsal surface of the hood, which is common in this species; 
and b - dark markings on the throat in front of the first dark ventral band (credit Mark 
O’Shea) 
Figure 1. 
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Figure	2.	
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Figure	3.	
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Figure	4.	
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Figure	5.	
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Figure	6.	
	
